Neurofeedback Therapy sessions last 60 minutes. Schedule Neurofeedback Therapy 2-3 times weekly for the number of sessions recommended by your physician and based on the purchased package. Schedule a baseline Brain Map or QEEG before starting Neurofeedback Therapy for customized protocol design and to evaluate concerns and observe benefit overtime.
Recent events regarding the long-term repercussions of traumatic brain injury have raised both our awareness and interest in applying effective restorative treatments. Symptoms of acute and chronic brain trauma include problems with attention, impulse and emotional control, memory loss, anxiety, insomnia, and depression. Symptoms arising from brain trauma are debilitating enough in some patients to affect ability to work, keep up in school, and sustain normal tasks of daily living. Mood disorders often rise straining relationships and reducing focus and executive functioning. It can quickly bring a normal life to a complete standstill.
Current guidelines still rely predominantly on watching and waiting. Following a mild TBI there are a few strategies that have been historically applied to help with cognitive restoration and functioning. Results are modest at best and leave some only partially recovered even after 18 months.
EVND takes a different approach that focuses on more recent evidence and experience suggesting early treatment produces better recoveries. Studies utilizing Neurofeedback have shown significant impact in just weeks with regard to restoration of brain processes toward “normal” or “historical” functioning. Reported benefits of neurofeedback treatment include improvement in short and long term memory, better attention and focus, sleep onset and quality, and improved mood. Neurofeedback has also been applied for the treatment of brain fog or cognitive changes following chemotherapy and radiation treatment, stroke, whiplash injuries, and chronic illness or infections.
Brain Trauma in the News
Recent studies are beginning to elucidate the depth and width of brain trauma associated with impact resulting in concussive injuries or mTBI. A recent article in the NY Times describes how brains react to impact and why stretching damage occurs deep in the brain. VIEW NOW
Enhance Neurological Repair & Regeneration
- Reduces Inflammation in the Brain
- Promotes Generation of New Tissue
- Improves Neuroplasticity
- Induces Remyelination
Improve Overall Function
- Advances Cognitive Function
- Improves Gross/Fine Motor Skills
- Enhances Speech & Language
- Alleviates Spasticity
- Stimulates Better Eye Contact
- Improves Balance & Walking
- Reduces Anxiety
- Reduces Depression
- Improves quality of sleep
BRAIN INJURY and CONCUSSION RECOVERY PROGRAMS
East Valley Naturopathic Doctors(EVND) offers affordable access to effective treatments directed toward those with recent or past head injuries. We continue to improve and provide services valuable to under treated patients within our communities such as those with head injuries arising from vehicular accidents, sports injuries, falls, and blast injuries.
We are of the belief that many symptoms following concussive events are treatable, and in many cases reversible, more so if therapy is started soon after the trauma. The first step is to become informed about the available treatments found in the research to be supportive of recovery. The following links below review the leading options for recovery from brain injuries.
Neurofeedback Therapy and improvements in Post Concussion Syndrome
FSM Therapy for improving energy and reducing inflammation
ACUTE CONCUSSION and mTBI PROGRAM
Acute head injuries which produce any obvious symptom within the first 36 hours can be greatly benefitted by the immediate application of Hyperbaric Oxygen Therapy. The number of sessions will depend upon the acute symptoms and the extent of the dysfunction produced by the head trauma. Generally 20 sessions are recommended to start, with some individuals requiring 40 total sessions before symptoms resolve.
Combining Hyperbaric Oxygen Therapy simultaneously with Frequency Specific Microcurrent (FSM) has been demonstrated to reduce inflammation and even heal nerve pathways that have been damaged due to concussive injuries. FSM therapy applies two simultaneous micro-currents which travel through the body to heal brain areas which have been damaged while reducing peripheral symptoms.
The Acute Concussion and mTBI Treatment Program is for patients with symptoms from a head trauma less than 3 months from the initial insult. The program combines two of the most valuable therapies (Hyperbaric Oxygen and Frequency Specific Microcurrent Therapy) into one program to treat, in the most thorough and efficient manner, the effects of acute Concussion or mild Traumatic Brain Injuries. We start with 20 sessions of Hyperbaric Oxygen Therapy and 10 sessions of Frequency Specific Microcurrent therapy to be completed over an approximate 4 weeks.
POST CONCUSSION SYNDROME and TBI RECOVERY PROGRAM
Chronic head injuries with a history of blast injuries, falls, sports injuries, and vehicular accidents, can leave lasting deficits which may not be immediately noticeable. Common complaints can include personality changes, sleep disturbance, anxiety, reduced tolerance to stress, headaches, depression, increased agitation, sensitivity to noise or light, reduced attention, and memory loss. The easiest method to acquire a baseline of brain function is to do a brain map or QEEG. Brain mapping evaluates hyper and hypo functioning of the various brain waves including Delta, Theta, Alpha, and Beta brainwaves. The brain waves provide a functional description of cognitive functioning, mood regulation, and even localized brain inflammation.
In addition to Hyperbaric Oxygen Therapy and Frequency Specific Microcurrent, Neurofeedback therapy also provides significant benefit in helping the brain rewire toward optimal functioning. The combined application of Neurofeedback with HBOT and FSM therapy promotes brain recovery by increasing oxygen, reducing inflammation, and healing nerve pathways in ways unmatched by any other course of treatment.
The Post Concussion Syndrome and TBI Recovery Program is for patients with symptoms from a head trauma that have persisted or worsened beyond 3 months from the initial insult. The program combines three of the most valuable therapies (Hyperbaric Oxygen, Neurofeedback, and Frequency Specific Microcurrent Therapy) into one program to both evaluate and treat, in the most thorough and efficient manner, the effects of chronic Post Concussive Syndromes or mild Traumatic Brain Injuries. We start with a baseline QEEG(brain map), then begin with 40 sessions of Hyperbaric Oxygen Therapy, 20 sessions of Neurofeedback Therapy, and 10 sessions of Frequency Specific Microcurrent therapy, to be completed over an approximate 8 weeks. We monitor the rehabilitation program with a comparison Brain Map or QEEG every 4 weeks and follow up visits with the physician as needed to review appropriate labs at 4 and 8 weeks.
Research Supporting Neurofeedback for TBI and Post Concussive Syndrome
Quantitative EEG Neurometric Analysis-Guided Neurofeedback Treatment in Postconcussion Syndrome (PCS): Forty Cases. How Is Neurometric Analysis Important for the Treatment of PCS and as a Biomarker?
Postconcussion syndrome (PCS) has been used to describe a range of residual symptoms that persist 12 months or more after the injury, often despite a lack of evidence of brain abnormalities on magnetic resonance imaging and computed tomography scans. In this clinical case series, the efficacy of quantitative EEG-guided neurofeedback in 40 subjects diagnosed with PCS was investigated. Overall improvement was seen in all the primary (Symptom Assessment-45 Questionnaire, Clinical Global Impressions Scale, Hamilton Depression Scale) and secondary measures (Minnesota Multiphasic Personality Inventory, Test of Variables for Attention). The Neuroguide Traumatic Brain Index for the group also showed a decrease. Thirty-nine subjects were followed up long term with an average follow-up length of 3.1 years (CI = 2.7-3.3). All but 2 subjects were stable and were off medication. Overall neurofeedback treatment was shown to be effective in this group of subjects studied.
The role of early posttraumatic neuropsychological outcomes in the appearance of latter psychiatric disorders in adults with brain trauma.
DISCUSSION: Post resuscitationThe objective was to determine the predictors of posttraumatic psychiatric disorders (PTPD) during the first 6 months following traumatic brain injury (TBI) focusing on neuroimaging, clinical and neuropsychological appraisements during acute and discharge phase of TBI.
MATERIALS AND METHODS: We designed a prospective, longitudinal study in which 150 eligible TBI patiePost-resuscitation brain injury severity and discharged functional outcome were evaluated by standard clinical scales. First Neuroimaging was done at a maximum of 24 h after head trauma. Early post-traumatic (PT) neuropsychological outcomes were assessed using Persian neuropsychological tasks at discharge. The standardized psychiatric assessments were carefully implemented 6 months postinjury. A total of 133 patients returned for follow-up assessment at 6 months. They were divided into two groups according to the presence of PTPD.
RESULTS: Apparently, aggression was the most prevalent type of PTPD (31.48%). There was no significant difference between groups regarding functional outcome at discharge. Diffuse axonal injury (12.96%) and hemorrhages (40.74%) within the cortex (42.59%) and sub-cortex (33.33) significantly occurred more prevalent in PTPD group than non-PTPD ones. Primary post resuscitation TBI severity, early PT lingual deficit and subcortical lesion on the first scan were able to predict PTPD at 6 months follow-up.
CONCLUSION: Almost certainly, the expansive dissociation risk of cortical and subcortical pathways related to linguistic deficits due to severe intracranial lesions over a period of time can augment possibility of subsequent conscious cognitive-emotional processing deficit, which probably contributes to later PTPD. Hence, early combined therapeutic supplies including neuroprotective pharmacotherapy and neurofeedback for neural function reorganization can dampen the lesion expansion and later PTPD.
Benefit of Neurofeedback on Post-Concussion Symptoms
In a recent pilot study, through the University of California at San Diego School of Medicine’s, retired military, who suffer from PTSD and TBI, are part of research showing the efficacy of Microcurrent Neurofeedback(IASIS). According to Dr. Mingxiong Huang, “In a veteran with mild traumatic brain injury(mTBI), substantial post-concussion symptoms(PCS) reductions were found after Micro Current Neurofeedback, as measured by the Rivermead PCS questionnaire. In one patient, total symptom score decreased from 46 (pretreatment) to 25 (post-treatment), with marked symptom decreases in headaches, forgetfulness, feeling frustrated or impatient, and sleep disturbance. Pretreatment showed abnormal Magnetoencephalography(MEG) slow-waves. Compared with pretreatment MEG, post-treatment MEG showed decreases in abnormal slow waves in the frontal pole, posterior cingulate cortex, right insular, and right hippocampus. MEG findings are consistent with the improvement of PCS for a headache (insular and PCC), memory function (hippocampus), and feeling frustrated or impatient (frontal pole).”
Mingxiong Huang Ph.D. who was the principal investigator of the Micro Current neurofeedback UCSD Pilot Study noted, “I was skeptical of the Micro Current Neurofeedback intervention; now I believe in this technology as an effective tool to reduce symptoms such as PTSD, mTBI, migraine, and headache, diminishing impulsivity and anxiety, and potentially helping with numerous other conditions such as addiction to smoking and nicotine, improving memory and sleep.”
- Clin EEG Neurosci. 2016 Jun 27. pii: 1550059416654849. Surmeli T1, Eralp E2, Mustafazade I3, Kos IH3, Özer GE2, Surmeli OH2.
- Asian J Neurosurg. 2015 Jul-Sep;10(3):173-80. doi: 10.4103/1793-5482.161165.
These statements have not been evaluated or approved by the FDA. All of the statements made on this document are not anecdotal and have been taken directly from clinical data.